EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 6

Lemon balm Melissa officinalis L.

Also called: melissa, balm

Lemon balm is a perennial herb of the mint family (Lamiaceae). Its leaves are used dried as herbal tea and in extracts and tinctures taken by mouth.

Category
Botanical
Part used
Leaf
Strongest evidence
B Some positive trials
Native range
Native from the Mediterranean to Central Asia
Reviewed
2026-10-28

Class 1 Well studied in people. A 2024 meta-analysis (BMC Complement Med Ther) pooled 5 RCTs (302 patients) of oral lemon balm alone (leaf powder, tea or extract) on blood lipids. [6]

Fact-checked 2026-10-28 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Lemon balm does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Lemon balm, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Anxiety symptomsBA meta-analysis of randomized trials found lower anxiety scores than placebo (SMD −0.98, 95% CI −1.63 to −0.33) without serious side effects; trials were few and heterogeneity was high. [1]
Depressive symptomsBThe 2021 Ghazizadeh meta-analysis found lower depression scores than placebo (SMD −0.47, 95% CI −0.73 to −0.21); the authors urged caution and called for higher-quality studies. [1]
Sleep disturbance with mild to moderate anxietyCThe EU assessment considered a small study suggesting improvement, but shortcomings in its design prevented firm conclusions. [3]
Premenstrual syndrome in adolescentsCOne double-blind trial in 100 girls aged 14–18 (1.2 g/day for 3 months) reported fewer psychosomatic problems on a well-being questionnaire than placebo. [2]

Main constituents: Phenolic acids (mainly rosmarinic acid and caffeic acid); essential-oil components citral, citronellal, geraniol and linalool; triterpenes ursolic and oleanolic acid [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Trials summarized in a 2024 review used, for example, 1.2 g/day for 3 months (PMS) and 2 g/day for 8 weeks (depression). [2]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated February 10, 2024.

    Details and sources
  • Pregnancy and breastfeeding
    Health Canada monograph: ask a health care practitioner before use if pregnant or breastfeeding.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Health Canada (monograph dated April 26, 2024), adolescents 12-17 and adults: 0.4-13.5 grams of dried herb top per day.

    Details and sources
  • Reviewed trials reported few side effects; up to 5,000 mg daily for 20 days was tolerated, but effects of higher doses or use beyond 56 days are unclear. [2]
  • At the time of the EU assessment no side effects had been reported; EU use is limited to adults and children over 12, with a doctor consulted if symptoms persist after 2 weeks. [3]
Quality

Identity, quality and standardization

  • Only six of the reviewed studies measured the phytochemical make-up of the lemon balm product they used. [2]
Regulation

Regulatory status

  • US: FDA states that, by law, it does not approve dietary supplements or their labeling before they are marketed; firms are responsible for the safety and labeling of their products. [5]
  • EU: an HMPC assessment supports traditional use (long-standing use, not clinical-trial proof) of melissa leaf for mild symptoms of stress, to aid sleep, and for mild digestive complaints such as bloating. [3]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Rosmarinic acid and caffeic acid (main phenolic acids) Phenolic acids [P1]
  • Ursolic acid and oleanolic acid Triterpenes [P1]
  • Aromatic oils, mainly citronellal and geranial; also glycosides, caffeic acid derivatives, flavonoids and triterpene acids Essential-oil components; phenolics; triterpene acids [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming lemon balm or Melissa officinalis was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P3]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of lemon balm (Melissa officinalis) was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P4]
  • NTP technical reports list checked 2026-10-29: no report on lemon balm. [P5]

Liver (NIH LiverTox)

  • LiverTox likelihood score E (unlikely cause of clinically apparent liver injury), chapter last updated February 10, 2024. Lemon balm is often included in multi-ingredient supplements implicated in liver injury, but a specific contribution from lemon balm could not be established. [P2]

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P6]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • No published information found in the sources checked.

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Health Canada (monograph dated April 26, 2024), adolescents 12-17 and adults: 0.4-13.5 grams of dried herb top per day. [P7]

Pregnancy and breastfeeding

  • Health Canada monograph: ask a health care practitioner before use if pregnant or breastfeeding. [P7]

Sources for this profile

  1. Mathews IM, et al. Clinical efficacy and tolerability of lemon balm (Melissa officinalis L.) in psychological well-being: a review. Nutrients 2024;16(20):3545 (PMID 39458539; two co-authors employed by an ingredient supplier), 2024-10-18. europepmc.org
  2. NIH LiverTox. Lemon Balm (last update February 10, 2024), 2024-02-10. ncbi.nlm.nih.gov
  3. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  4. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  5. National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  6. eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  7. Health Canada, NNHPD. Monograph: Lemon Balm - Melissa officinalis (date 2024-04-26), 2024-04-26. webprod.hc-sc.gc.ca
Sources

Sources

  1. Ghazizadeh J, et al. The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: a systematic review and meta-analysis. Phytother Res 2021;35(12) (PMID 34449930), 2021-12. pubmed.ncbi.nlm.nih.gov
  2. Mathews IM, et al. Clinical efficacy and tolerability of lemon balm (Melissa officinalis L.) in psychological well-being: a review. Nutrients 2024;16(20):3545 (PMID 39458539; two co-authors employed by an ingredient supplier), 2024-10-18. europepmc.org
  3. European Medicines Agency, HMPC. Melissae folium (melissa leaf) - herbal medicinal product (last updated 16/06/2014), 2014-06-16. ema.europa.eu
  4. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data (Govaerts et al., Sci Data 2021). Melissa officinalis L. (accessed 2026-10-28; Kew cannot warrant the accuracy of the data). powo.science.kew.org
  5. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  6. Shahsavari K, et al. Effects of Melissa officinalis (lemon balm) consumption on serum lipid profile: a meta-analysis of randomized controlled trials. BMC Complement Med Ther 2024;24(1):146 (PMID 38575930), 2024-04-04. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.